HDL was used as a nanoplatform for the co-delivery of a fluorescent dye and a small interfering RNA (siRNA) for Hypoxia-inducible factor 1-alpha (HIF-1α) for enhanced photo-gene therapy towards glioma. This evidence concerns the gene HIF1A and central nervous system cancer.